Akorn Seeks Del. Ch. 11 OK For $9M Stockholder Suit Deal
Bankrupt biopharmaceutical company Akorn Inc. sought a Delaware court's approval late Wednesday for an at least $9 million global settlement of holdout-stockholder suits targeting the company for regulatory and data integrity...To view the full article, register now.
Already a subscriber? Click here to view full article